2162 — Keymed Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Keymed Biosciences, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	354	3,525	3,175	2,719	2,156
Net Total Accounts Receivable
Net Total Receivables	1.23	13.6	7.44	79.6	62.9
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	381	3,582	3,310	2,940	2,466
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	126	306	596	911	1,048
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	530	3,934	3,932	3,883	3,767
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	80.2	112	380	314	748
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,624	283	592	897	1,292
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	-1,095	3,651	3,340	2,986	2,475
Total Liabilities & Shareholders' Equity	530	3,934	3,932	3,883	3,767
Total Common Shares Outstanding